Ethylene Glycol (CAS RN 107-21-1) can cause kidney toxicity via the formation of calcium oxalate crystals in a variety of species including humans. Numerous repeated dose studies conducted in rats have indicated that male rats are more susceptible than female rats.
Introduction
Ethylene glycol (CAS RN 107-21-1) is an intermediate in the synthesis of a number of commercial chemical products, including polyethylene terephthalate (PET) resins, unsaturated polyester resins, polyester fibers and films. It is also a constituent in antifreeze, deicing fluids, surface coatings, heat transfer fluids and industrial coolants, hydraulic fluids, surfactants and emulsifiers (CERHR, 2003) . General population, or consumer, exposure occurs primarily from the use of ethylene glycol in automotive antifreeze. There have been a number of acute human poisonings from accidental or intentional ingestion of antifreeze, with the kidney being the most sensitive target organ. Regimens for the treatment of acute ethylene glycol poisoning are designed to prevent metabolism to the toxic acidic metabolites, to treat acidosis, and to prevent kidney damage (Brent et al., 1999; Barceloux et al., 1999) .
Numerous repeated-dose studies in a variety of species have evaluated the toxicity of ethylene glycol. Although considerable variability has been observed in sensitivity across species, strains and sexes, these studies have consistently identified the kidney as a primary target organ, with rats being more sensitive than mice and males more sensitive than females following chronic exposure. Furthermore, there appears to be a strain difference in sensitivity to ethylene glycolinduced nephrotoxicity in rats which can impact human health risk assessments. In the 1970s, the British Industrial Biological Research Association [BIBRA] fed Wistar rats diets with constant concentrations of ethylene glycol (0, 500, 1000, 2500, or 10,000 ppm) for 16 weeks (Gaunt et al., 1974) . As typical for studies starting when the animals were young, the amount of feed consumed per kilogram of body weight decreased about three-fold over the 16 weeks of the study. Therefore, the dosage of ethylene glycol in each group was considerably higher during the Revised manuscript 061104, page 6 first week (1410 mg/kg/day for males and 1782 mg/kg/day for females in the high concentration group) than during the 16th week (512 and 910 mg/kg/day for males and females, respectively).
The authors reported calcium oxalate crystals in the kidneys of high-dose male rats (average daily dosage of 715 mg/kg/day) resulting in degeneration of kidney tubules. One rat at an average daily dosage of 180 mg/kg/day had observation of individual nephrons with degenerative changes and occasional oxalate crystals. The NOAEL was reported as 71 mg/kg/day.
A two-year chronic toxicity/oncogenicity study was conducted a few years later in a US laboratory using F-344 rats (DePass et al., 1986) . Target dosages in mg/kg/day were determined before study start and the concentration of ethylene glycol in the diet was adjusted periodically to maintain the appropriate mg/kg/day dosage based upon group mean body weights and feed consumption. At 40 and 200 mg/kg/day, no toxicity or increased tumor incidence was seen in male or female rats. At 1000 mg/kg/day, no early mortality or increased tumor incidence was reported in female rats; however, nephropathology was seen. In male rats exposed to 1000 mg/kg/day, early mortality was seen beginning at about 12 months. By 15 months, all high-dose males had died. Pathologic evaluation revealed extensive kidney damage as the cause of death.
In this study the NOAEL was 200 mg/kg/day, approximately three-fold higher than observed in the 16-week Wistar rat study.
Mice have been shown to be considerably less sensitive than rats following chronic dietary exposures to ethylene glycol (NTP, 1993) . No increased tumors or toxicity were reported in male Revised manuscript 061104, page 7 mice exposed to calculated average doses of 1500, 3000 or 6000 mg/kg/day or in female mice exposed to 3000, 6000, or 12,000 mg/kg/day for 2 years.
Thus, there are two repeated-dose studies in two different strains of rats in which males were more sensitive than females, and Wistars more sensitive than F344 rats (NOAEL of 200 mg/kg/day in male F344 rats following 2 years of exposure vs. NOAEL of 71 mg/kg/day in male Wistar rats following 16 weeks of exposure). This apparent difference in strain sensitivity could potentially be due to differences in the susceptibility of renal tubule cells to calcium oxalate crystals or to potential differences in the toxicokinetics of ethylene glycol leading to a localized buildup of calcium oxalate crystals. Thus, research is underway to evaluate the potential toxicokinetic and toxicodynamic contributions to ethylene glycol-induced renal toxicity to assist in human health risk assessments. As a part of this program, a 16-week subchronic toxicity study was conducted to directly compare the toxicity of ethylene glycol in male F-344 and Wistar rats under identical dietary exposure conditions. Subgroups of animals were also included to determine the levels of ethylene glycol and its toxic metabolites, glycolic acid and oxalic acid, in blood, urine and kidneys following 1 and 16 weeks of exposure to provide insights into the potential role of toxicokinetics in the sensitivity differences between rat strains.
Methods:
Study design: Groups of 10 male F-344 and Wistar rats were administered ethylene glycol via the diet at targeted dosage levels of 0 (control), 50, 150, 500 or 1000 mg/kg/day for 16 weeks.
Dietary concentrations were adjusted weekly based upon group mean body weights and feed consumption for each group of rats. At the end of 16 weeks of exposure, each animal received a complete necropsy with kidneys evaluated by histopathology. Toxicokinetic satellite groups Revised manuscript 061104, page 9 ad libitum via an automatic system, except when water consumption was measured from water bottles. Revised manuscript 061104, page 10 Diet preparation: Doses of 0, 50, 150, 500, and 1000 mg/kg/day were chosen to cover the range of doses in the Gaunt et al., 1974 and DePass et al., 1986 studies. Concentrations of ethylene glycol in the diets were calculated weekly for each group of Wistar and F-344 rats based upon the most recent group mean body weights and amounts of feed consumed to achieve the targeted dosages. For each mixture, the needed amount of ethylene glycol was weighed and mixed into an appropriate amount of NTP2000 diet (Ziegler Bros, Inc.) using a Hobart blender. The test diets were prepared weekly and stored under ambient conditions. The concentrations of ethylene glycol in the diets were confirmed by gas chromatography during weeks 0, 1, 2, 3, 4, 8 and 15.
Test
Toxicity assessment: Animals were observed for clinical signs of toxicity daily with detailed physical examinations conducted on all animals weekly. Each animal was weighed weekly.
Extensive hematological, urinalysis and clinical chemistry analyses were conducted in the prior subchronic and chronic studies. Therefore, only limited urinalyses were conducted in this study as a complement to the renal pathology examinations. Urine was collected over an approximately 24-hour period prior to necropsy for all animals (fasted) using metabolism cages. The following parameters were evaluated: specific gravity (ATAGO Urine Specific Gravity Refractometer), pH, color, appearance, protein, glucose, bilirubin, urobilinogen, ketones, occult blood, leukocytes, nitrites (CLINITEK ® 200+ Urine Chemistry Analyzer with reagent strips from Bayer), total volume, color, appearance, and microscopy of sediment.
Pathology: After 16 weeks of treatment, all survivors were euthanized and necropsied. Selected tissues (44/animal) were preserved in neutral buffered formalin for potential future evaluations.
Since the mode of action of ethylene glycol is well-documented and complete histopathological analyses were conducted in prior subchronic and chronic studies, the focus of the pathology Revised manuscript 061104, page 11 examinations in this 16-week study was limited to the kidneys. The kidneys were weighed and the ratio to the terminal body weight were calculated. Sections of each kidney (one longitudinal in a mid-sagittal position and from the other kidney, a transverse section through the renal papilla) were imbedded in paraffin, processed and cut at 5 micron thickness and mounted on glass microscopic slides and stained with hematoxylin-eosin. The slides were examined by normal light (brightfield) for pathologic lesions, polarized light for the presence of oxalate crystals (Khan et al, 1982; Rushton et al, 1981) , and fluorescence microscopy for the presence of lysosomes (Maunsbach, 1966; Hard and Snowden, 1990) . The severity of compound-induced nephropathy was graded on a scale of 1-5, and crystal deposition on a scale of 1-4 (see Tables 3 and 4 for description of grades).
Toxicokinetics: Satellite groups of 5 rats/strain/dose level were administered ethylene glycol in the diets at 0, 150, 500 and 1000 mg/kg/day for either one or sixteen weeks of exposure. For 24 hours prior to euthanasia, urine was collected while each animal was housed separately in metabolism cages. Prior to euthanasia a blood sample was obtained. At euthanasia, the kidneys were removed. All samples were flash-frozen in liquid nitrogen and shipped on dry ice from WIL Research Laboratories, Inc. to Battelle Northwest. Samples were stored frozen (-80°C) until analyzed, generally within a few weeks of collection. Previous studies have shown that samples prepared and stored in this manner remain viable for analysis of ethylene glycol, glycolic acid and oxalic acid for up to 542 days (Corley et al., 2002 ).
Blood and urine samples were analyzed for ethylene glycol, glycolic acid, and oxalic acid by gas chromatography/mass spectrometry (GC/MS) using the general extraction and derivatization methods of Pottenger et al. (2001) . 2-Butoxyethanol and deuterated ethylene glycol and glycolic for ethylene glycol (EG), glycolic acid (GA) and total oxalic acid (OX), respectively in blood; 0.8, 0.5 and 0.6 µg/g for EG, GA and OX, respectively, in kidneys; and 0.5 and 20.6 µg/g for GA and OX, respectively, in urine and cage wash samples. For groups with samples below the limits of quantitation (LOQ), the LOQ/2 was used to calculate the means and standard deviations.
Due to the high concentrations of ethylene glycol in urine and cage wash samples, direct analysis of these samples was performed by gas chromatography with flame ionization detection (GC/FID) on a Hewlett Packard 6890 gas chromatograph The limits of quantitation (LOQ) for EG in these samples was 2.4 µg/g.
Statistics:
Body weight, body weight change, feed consumption, urinalysis and kidney weight data were subjected to a parametric one-way analysis of variance (ANOVA) to determine intergroup differences. If the ANOVA revealed statistical significance (p<0.05), Dunnett's test was used to compare the test article-treated groups to the control group.
Results:
In-Life: There were no other deaths and no clinical signs of toxicity. Wistar rats dosed at 500 and 1000 mg/kg/day had lower mean body weights ( Figure 1 ) in comparison to the controls throughout the study. Following 16 weeks of treatment, the mean body weight in the 1000 mg/kg/day Wistar group was approximately 23% lower than the control group, while that in the 500 mg/kg/day Wistar group was 9% lower than the control group. Treatment of Wistar rats at 50 and 150 mg/kg/day had no effect on body weight. Ethylene glycol had no effect on body weight at any dosage level in F-344 rats.
Treatment of Wistar rats at 1000 mg/kg/day resulted in reduced feed consumption, which became more pronounced after week 8. At 500 mg/kg/day, Wistar rats ate slightly less feed than the controls. F-344 rats receiving 1000 mg/kg/day consumed ~4% less feed than the F-344 controls (data not shown).
The calculated compound intakes for both F-344 and Wistar rats were within 10% of intended targets on each weekly measurement (Figure 2 ). For Wistar rats at 1000 mg/kg/day, the decreasing food consumption after week 8 resulted in increasing concentrations of ethylene glycol in the feed; even so, compound intake was 5-10% below intended the last 7 weeks.
In the 1000 mg/kg/day F-344 group and in the 500 and 1000 mg/kg/day Wistar groups, the amounts of water consumed were significantly increased compared to controls (~200%), which resulted in higher total urine volumes (170 -300%), and lower urine specific gravities (Table 1 ).
These groups also had higher incidences in the occurrence of white blood cell (microscopy) and/or leukocyte esterase (dipstick) estimates (data not shown). Other urine parameters were unaffected by treatment. There were increased incidences of calcium oxalate crystals in the urine of the 150, 500 and 1000 mg/kg/day F-344 and Wistar groups (Table 1) .
Pathology:
Mean absolute and relative (to final body weight) kidney weights (Table 2) in the 1000 mg/kg/day F-344 and 500 and 1000 mg/kg/day Wistar groups were significantly (p<0.05 or 0.01) higher than the control group at the scheduled necropsy.
With examination by brightfield microscopy (Table 3) , all Wistar rats receiving 500 and 1000 mg/kg/day of ethylene glycol showed evidence of crystal deposition in the kidney and an associated compound-induced nephropathy. The crystals were lodged in the tubule lumens, particularly proximal tubules in severe cases. The typical cuboidal epithelial lining of tubules containing crystals was reduced to a flattened and attenuated appearance. The nephropathy was characterized by foci or linear tracts of tubule basophilia associated with thickened basement membrane (or in advanced cases, interstitial hyalinization), interstitial inflammation (predominantly mononuclear) and fibroblastic reaction, occasional single cell degeneration and mitoses in the affected tubules, usually some tubule dilation, and in advanced cases, sporadic cellular casts. There was an associated hyperplasia of the lining of the renal pelvis, and sometimes mild pelvic dilation. Crystals were invariably observed in the fornix of the renal pelvis, even in the least affected cases, but in severe cases the papilla tip was disrupted by outpouchings of crystal deposits. These various microscopic aspects of crystal nephropathy reflected the range of gross changes seen at autopsy in these dose groups, namely, rough or pale kidney surface, white areas in cortex/medulla, multiple pinpoint calculi, and dilated pelvis. With
Revised manuscript 061104, page 15 evaluation under polarized light (Table 4) , the crystals appeared as birefringent polycrystalline particles arranged in rosette or fan-shaped patterns, or individually as near-rectangular plates.
Nephropathy with crystal deposition was most severe in Wistar rats administered ethylene glycol at 1000 mg/kg/day, where end-stage (grade 5) change affected 4 of the 10 rats, two of which died before the scheduled necropsy. Crystal deposition in the kidney and associated nephropathy were also observed in all F-344 rats at the highest dose of 1000 mg/kg/day, but at a lesser severity.
Crystal-induced nephropathy was observed in all Wistar rats treated at 500 mg/kg/day, but in only 1 of 10 F-344 rats treated at 500 mg/kg/day. Six additional rats in the F344 group dosed with 500 mg/kg had evidence of crystals, but without involvement of the renal parenchyma. In each case these were represented by a solitary, small, birefringent crystal lodged in the fornix of the renal pelvis.
The severity of crystal nephropathy at 1000 mg/kg/day in F-344 rats was approximately equivalent to that seen at 500 mg/kg/day in Wistar rats. No crystal nephropathy was seen in either Wistar or F-344 rats at 50 or 150 mg/kg/day.
Toxicokinetics:
In the satellite toxicokinetic group of animals, trace levels of glycolic acid and oxalic acid were found occasionally in the blood, kidneys and urine of control animals. Both glycolic acid and oxalic acid are known products of endogenous biosynthesis or are metabolites of dietary constituents and were, therefore expected to be present in control samples, albeit at very low concentrations relative to levels achieved following treatment with ethylene glycol at the high dosage levels used in this study. (Table 5 ). Although only a single blood sample was analyzed for each animal, blood levels of ethylene glycol were generally consistent with first-order, non-saturable metabolism in both strains of rats, similar to previous observations in Sprague-Dawley rats (Pottenger et al. 2001 ). Blood ethylene glycol levels in the 16-wk Wistar satellite group were consistently lower than concurrent F344 blood and previous 1-wk blood levels in Wistar rats.
Analysis of blood
This likely reflected differences in the timing of the blood collections vs. the time the animals consumed their diets as the half-life for ethylene glycol is on the order of 1.4-1.9 hr and the levels of metabolites were correspondingly higher in these samples (Pottenger et al., 2001 ).
Glycolic acid levels in blood remained very low at 150 and 500 mg/kg/day in both strains of rats following one and 16 weeks of exposure. This was expected since these lower dietary exposures did not generate sufficient glycolic acid levels to result in saturation of its metabolism (Pottenger et al., 2001; Carney et al., 2002; Corley et al., 2002) . At 1000 mg/kg/day, blood levels of glycolic acid were increased in F-344 and Wistar rats following 1 and 16 weeks of exposure, indicating that this dose level resulted in the saturation of glycolic acid metabolism.
Oxalic acid levels in blood were generally near background levels in all groups except for small increases in the F-344 and Wistar rats exposed for 16 weeks to the 1000 mg/kg/day. Even at 1000 mg/kg/day, blood levels of oxalic acid rarely exceeded 20 µg/g (background blood levels generally ranged from 1-10 µg/g in previous studies; Pottenger et al., 2001; Carney et al., 2001;  Revised manuscript 061104, page 17 Corley et al., 2002) , primarily due to solubility limits (Burgess and Drasdo, 1993; Hodgkinson, 1981) . (Table 6 ). Ethylene glycol and glycolic acid levels in the kidneys of both F-344 and Wistar rats were very similar to their corresponding blood levels with levels increasing as exposure duration increased. In F-344 rats, ethylene glycol kidney levels were consistently 2-3-fold higher following 16 weeks than observed following one week of exposure. This difference was less apparent or nonexistent in Wistar rats.
Analysis of kidneys
For glycolic acid, a nearly 5-fold increase in the concentration in the kidneys of Wistar rats was observed following 16 weeks of exposure to 500 and 1000 mg/kg/day than was observed following only 1 week of treatment. In F-344 rats, exposure-duration effects on glycolic acid levels in kidneys was only apparent at 1000 mg/kg/day where levels were increased ~3-fold over one week of exposure.
Following one week of exposure, oxalic acid levels in the kidneys of F-344 rats at 1000 mg/kg/day were elevated, while in Wistar rats at 500 and 1000 mg/kg/day, oxalic acid levels in the kidneys were elevated. Following 16 weeks of exposure, oxalic acid levels were elevated in the kidneys of F-344 rats at 500 and 1000 mg/kg/day and at 150, 500 and 1000 mg/kg/day in Wistar rats. Thus, oxalic acid levels demonstrated significant dose-and time-responses to ethylene glycol dietary exposures with significantly higher levels achieved in Wistar rats, consistent with the observed strain differences in renal toxicity. (Table 7) . Elimination of ethylene glycol into the urine was largely a firstorder process, consistent with previous studies (Pottenger et al., 2001; Corley et al., 2002 ) except for Wistar rats exposed for 16 weeks to 500 and 1000 mg/kg/day, where the clearance of ethylene glycol and its metabolites were significantly reduced by the extensive toxicity. The amounts of glycolic acid excreted in the urine also demonstrated non-linearities with significantly higher amounts excreted by both strains of rats following one week of exposure to ethylene glycol at 1000 mg/kg/day. However, following 16 weeks of exposure, renal toxicity observed in F-344 rats at 1000 mg/kg/day and in Wistar rats at 500 and 1000 mg/kg/day appeared to reduce the amounts of glycolic acid excreted in the urine. Oxalic acid levels in urine, although variable, were clearly elevated at the top two dose levels in F344 rats and all dose levels in Wistar rats except at 16 weeks, where renal toxicity impaired excretion.
Analysis of urine
As shown in Figure 3 , the percentage of administered doses accounted for by ethylene glycol, glycolic acid and oxalic in urine was remarkably consistent in every group of animals except Wistar rats exposed for 16 weeks to ethylene glycol at 500 and 1000 mg/kg/day. At these higher dose levels in Wistar rats, the severe renal toxicity likely impaired the ability to excrete ethylene glycol and its metabolites resulting in significant reductions in the percentage of the dose eliminated in the urine. This reduced clearance may have further exacerbated the renal toxicity.
Benchmark Dose Analysis
Benchmark dose analysis of the incidence of crystal nephropathy by brightfield microscopic examination in Wistar rats using the multistage model (USEPA's BMDS program Version 1.3.1)
Revised manuscript 061104, page 19 resulted in a BMD05 of 161 mg/kg/day and a BMDL05 of 71.5 mg/kg/day. The same analysis of the F-344 data resulted in a BMD05 of 417 mg/kg/day and a BMDL05 of 285 mg/kg/day.
Discussion:
The postulated mode of action by which ethylene glycol causes renal toxicity in rats is through the metabolism of ethylene glycol to oxalic acid and the precipitation of oxalic acid with calcium. Oxalic acid does not appear to be formed from ethylene glycol in the kidneys of rats, indicating that it must be transported from the liver (Liao and Richardson, 1972) . Oxalic acid has a very low solubility in aqueous systems; thus blood levels of oxalic acid typically don't rise above 10-20 mg/L (0.1-0.2 mM), regardless of dose (Burgess and Drasdo, 1993; Hodgkinson, 1981; Pottenger et al., 2001) . As oxalate ions are concentrated prior to clearance in urine, they can precipitate with calcium ions which leads to the growth of insoluble calcium oxalate crystals in the renal tubule epithelium.
A distinction needs to be made between the presence of oxalate, a metabolite of ethylene glycol, and calcium oxalate-induced toxicity. In the current study, calcium oxalate crystals were seen in the urine of Wistar rats dosed at 150, 500 and 1000 mg/kg/day, but crystals were seen in the kidney only at 500 and 1000 mg/kg/day, while in F-344 rats, crystals were seen in the urine at 500 and 1000 mg/kg/day, but were observed in the kidney parenchyma of only 1 of 10 rats at 500 mg/kg/day and in all 10 at 1000 mg/kg/day. Thus calcium oxalate crystals can be present in the urine without being detected in the renal tubule lumen and without kidney pathology. It is believed that calcium oxalate crystals in the renal tubule lumen result in renal cell injury leading to cell death. As more of the kidney is impaired, normal kidney water regulation is compromised, as evidenced by increased urine volume and decreased urine specific gravity leading to increased water consumption (Table 3) . Ethylene glycol itself may also act as an osmotic diuretic in renal tubules, contributing to the increased volume and decreased specific gravity of urine.
Humans appear to handle ethylene glycol in a qualitatively similar manner to animals.
Following intentional high acute oral doses, ethylene glycol has been observed to be converted to glycolic and oxalic acid, leading to metabolic acidosis and eventually kidney damage. Treatment of acute ethylene glycol poisoning in animals and humans has therefore consisted of administration of ethanol or 4-methylpyrazole to inhibit the metabolism of ethylene glycol by alcohol dehydrogenase and gastric lavage and hemodialysis to hasten the elimination of ethylene glycol and its metabolites (Baud et al., 1987 and Bowen et al., 1978; Brent et al., 1999; Cheng et al., 1997; Eder et al., 1998; Gordon and Hunter, 1982; Harry et al., 1994; Hewlett and McMartin, 1986; Jacobsen et al., 1984 and Karlson-Stiber and Persson, 1992; Malmlund et al., 1991; Siew, 1979; Simpson, 1985; Spillane et al., 1991; Walder and Tyler, 1994) . The mode of action may explain the delays observed in renal toxicity in human acute poisoning cases and in repeated-dose animal studies. Kidney damage occurs after metabolic conversion of ethylene glycol in the liver, the slow transport of oxalic acid to the kidneys (due to low blood solubility) and the precipitation of the resulting oxalic acid with calcium. In human poisoning cases, the damage to the kidneys can be either reduced or prevented if treatment is instituted soon after consumption (Brent et al, 1999) .
The presence of calcium oxalate crystals in the kidney tubule prevents normal kidney function at that site and leads to cell death. Eventually, the kidney may be so compromised that it has a reduced capacity to excrete oxalates, resulting in greater kidney burden of oxalic acid and calcium oxalate. Due to the use of strong acid in extraction procedures, calcium oxalate is converted to oxalic acid in all chemical analyses. Thus, particularly in kidney tissues, the oxalic acid detected was likely to consist primarily of calcium oxalate. After 16 weeks of ethylene glycol dietary exposures oxalic acid accounted for ~2-3% of the kidney weights of Wistar rats in the 500 mg/kg/day group and of F-344 rats in the 1000 mg/kg/day group. In Wistar rats in the 1000 mg/kg/day group, oxalic acid accounted for as much as 10% of the kidney weight or as much as 18%, if it were all in the form of calcium oxalate. If the damage is sufficient as it was with the some of Wistar rats dosed at 1000 mg/kg/day, death may occur.
In F-344 rats, exposure to 1000 mg/kg/day for 12 months resulted in oxalate crystal nephropathy leading to the death of all males rats before the end of the 24-month study. However, no oxalate crystal nephropathy was seen in rats dosed at 200 mg/kg/day for 24 months (DePass et al., 1986 ).
On the other hand, the unpublished study in Wistar rats (Gaunt et al., 1974) mg/kg/day is about the same as seen in F-344 rats at 1000 mg/kg/day). Benchmark dose analysis of the incidences of crystal nephropathy indicated that the BMDL05 for F-344 rats is about fourfold higher than that of Wistar rats.
The toxicokinetic data generated in this study support the mode of action and differing susceptibility of Wistar and F-344 rats. After one week of exposure at 150 mg/kg/day, there was essentially no difference between Wistar and F-344 rats in urinary excretion of ethylene glycol, glycolic acid, or oxalic acid. At 500 and 1000 mg/kg/day, F-344 rats excreted more ethylene glycol and glycolic acid, but less oxalic acid than Wistar rats. The effect of kidney pathology on ethylene glycol removal was evident in Wistar rats, but not F344 rats after 16 weeks of treatment. F-344 rats excreted the same proportion of the administered dosage after 16 weeks (23-25%) as after 1 week (22-27%); however, Wistar rats treated at 500 and 1000 mg/kg/day had severely reduced excretion (from 18-19% to 3-5%).
The reduced clearance of ethylene glycol and its metabolites ultimately led to significantly greater target tissue levels of oxalic acid (presumably in the form of calcium oxalate) in male Wistar rats than in male F344 rats. Based upon results from an ongoing series of in vitro metabolism studies, there do not appear to be significant differences between strains of rats in the relative rates of metabolism when glycolic acid is used as a substrate (manuscript in preparation).
Furthermore, there do not appear to be significant strain differences in susceptibility to calcium oxalate crystals in ongoing in vitro toxicity studies (manuscript in preparation). It is thus likely that the differential susceptibility to ethylene glycol toxicity may be due to differences in renal clearance of oxalic acid (or calcium oxalate).
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Oxalic acid does not appear to bind to plasma proteins and is freely filtered by the glomerulus.
The ratio of oxalic acid renal clearance (CL OX ) to inulin clearance (CL In ), a measure of glomerular filtration rate, is generally 1.12-2.06 in a variety of species (Boer et al., 1985; Cattell et al., 1962; Knight et al., 1979a, b; McIntosh and Belling, 1975; Osswald and Hautmann, 1979; Prenan et al., 1982) , suggesting that there is net active secretion of oxalate into the tubule for excretion. Oxalic acid can either be excreted in urine within its solubility limits (solubility of calcium oxalate in deionized water is ~4.2-7.4 mg/L; Burgess and Drasdo, 1993; Hodgkinson, 1981) or precipitate with calcium to begin the process of forming crystals (which may also be excreted in the urine). With such a low pka (pka 1 = 1.2 and pka 2 =3.8; Greger, 1981) , no iontrapping is expected as oxalic acid is in its ionized state at all physiological pH's. At present, these data do not indicate whether major differences between male Wistar rats and other rat strains is likely associated with differences in the active transport of oxalic acid into the tubule or in glomerular filtration.
While high acute oral doses of ethylene glycol can cause calcium oxalate-induced kidney toxicity in humans who may have accidentally or intentionally consumed antifreeze, chronic exposures to ethylene glycol in humans are apparently quite low and nephropathy has not been observed in workers as a consequence of ethylene glycol exposure. In an occupation with perhaps the greatest potential for exposure to ethylene glycol, no demonstrable kidney damage was observed in 33 adult male Canadian airport deicing workers (Gerin et al., 1997) . In addition, no clear evidence of kidney toxicity was observed in a group of 10 male Finnish auto mechanics although urinary ethylene glycol levels were significantly elevated relative to age-matched male office workers (Laitinen et al., 1995 In summary, this study has confirmed the considerable strain variability in sensitivity to ethylene glycol-induced renal toxicity and that this sensitivity may be related to differences in the ability to clear ethylene glycol and its metabolites, most notably oxalic acid (or calcium oxalate), in the urine. To explain the mechanism for the strain differences, additional studies are in progress to examine: 1) the inherent sensitivity of Wistar rat, F-344 rat, and human proximal tubule epithelial cells; 2) the conversion of ethylene glycol to glycolic and oxalic acid; 3) the renal clearance of oxalate as a function of strain and ethylene glycol exposure. These additional studies, along with the results from this 16 week study and an ongoing chronic toxicity/toxicokinetic study, should provide a more definitive and quantitative basis for extrapolating results from either strain of rat in human health risk assessments.
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